Full Text View
Tabular View
No Study Results Posted
Related Studies
Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease (HaploSCD)
This study is currently recruiting participants.
Verified February 2013 by New York Medical College
Study NCT01461837   Information provided by New York Medical College

First Received on October 19, 2011.   Last Updated on February 4, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sickle Cell Disease
Additional conditions recognized in this trial
Anemia, Sickle Cell
More general conditions related to this trial
Anemia
Anemia, Hemolytic
Anemia, Hemolytic, Congenital
Genetic Diseases, Inborn
Hematologic Diseases
Hemoglobinopathies
Sponsors listed in this trial
New York Medical College
Children's Hospital & Research Center Oakland
Medical College of Wisconsin
Washington University School of Medicine
Tufts University
University of California, San Francisco
Miltenyi Biotec GmbH
Otsuka Pharmaceutical Development & Commercialization, Inc.
FDA Office of Orphan Products Development


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services